-
Freshpet: A Clear Show Me Story For 2016
Tuesday, January 19, 2016 - 5:45pm | 317Read More...Canaccord analyst Mark Sigal reiterated a Buy rating on Freshpet Inc (NASDAQ: FRPT) on Tuesday. However, the analyst fine-tuned his estimates after the ICR conference, and consequently trimmed his price target on the stock from $11 to $9. Shares of Freshpet were trading down more than 4.2...
-
What Everyone's Saying About Under Armour's New CFO
Wednesday, December 23, 2015 - 2:32pm | 695Read More...Under Armour Inc (NYSE: UA) announced on Tuesday that it had appointed Chip Molloy as its new Chief Financial Officer. Molloy was picked to replace the current CFO, Brad Dickerson, who will leave the company in February. Responding to the news, shares were trading up roughly 2 percent on...
-
Avago's Q3 Aftermath: What Top Wall Street Analysts Are Saying
Friday, December 4, 2015 - 9:52am | 914Read More...Avago Technologies Ltd (NASDAQ: AVGO) reported its fourth-quarter financial results on Wednesday afternoon. Earnings of $2.51 per share and revenue of $1.853 billion came in ahead of the Street’s consensus, which called for earnings of $2.38 per share and sales of $1.85 billion. The...
-
Wall Street Remains Bullish On Box Following Q3 Earnings Tumble
Thursday, December 3, 2015 - 5:28pm | 334Read More...Box Inc (NYSE: BOX) reported solid Q3 numbers, but the market punished the stock in Thursday’s trading session. With Box down 9 percent following earnings, here’s a look at what four Wall Street firms had to say about the stock post-earnings. Oppenheimer Analyst Ittai Kidron...
-
Canaccord Downgrades Abengoa Yield Amid 'Confusion'
Monday, November 30, 2015 - 9:46am | 188Read More...Canaccord Genuity on Monday downgraded Abengoa Yield PLC (NASDAQ: ABY) amid corporate structure and growth concerns. The firm now rates Abengoa as a Hold and lowered the stock's price target from $29.50 to $16. Analysts John Quealy and Chip Moore wrote, "While we find the return of ex-...
-
Canaccord Sees Opower As Top 'Bounce Back' Candidate For 2016
Wednesday, November 11, 2015 - 3:13pm | 428Read More...Shares of Opower Inc (NYSE: OPWR) were trading up about 2 percent on Wednesday. The company reported above-consensus third-quarter financial results after the market closed on Tuesday. Following the earnings call, analysts at Canaccord reiterated a Buy rating and $14 price target on the shares....
-
Meet Gulfport Energy, Canaccord's Latest Buy Target
Wednesday, October 21, 2015 - 12:40pm | 330Read More...Canaccord initiated coverage of Gulfport Energy Corporation (NASDAQ: GPOR) with a Buy rating and $48.00 price target on Wednesday. Shares of Gulfport were down roughly 2.5 percent on Wednesday. Analyst Stephen Berman argued that it is “the most levered company to the core of the...
-
iRobot Investors: So You're Tellin' Me There's A Chance
Wednesday, October 21, 2015 - 12:28pm | 364Read More...In a report issued Tuesday, analysts at Canaccord reiterated a Buy rating and $40.00 price target on shares of iRobot Corporation (NASDAQ: IRBT). They viewed trimmed 2015 guidance as “a buying opportunity” and expected Wednesday’s likely pullback for the stock to be short-...
-
Cree Getting Mixed Reviews On Wall Street
Wednesday, October 21, 2015 - 11:20am | 422Read More...Cree, Inc. (NASDAQ: CREE) reported in-line earnings and a revenue beat in its most recent quarter. Negative reaction to earnings is likely due to the company’s relatively weak guidance. Wall Street is mixed when it comes to the future for Cree. Wall Street appears to have a mixed view of...
-
The Street's Take On Advanced Micro Devices' Earnings Report
Friday, October 16, 2015 - 2:23pm | 606Read More...Advanced Micro Devices, Inc. (NASDAQ: AMD) reported a net loss of ($0.17) per share on revenue of $1.061 billion on Thursday afternoon, missing the Street’s consensus earnings estimate of ($0.11) per share. Advanced Micro Devices beat on the revenue front, however, where expectations stood...
-
Canaccord Reduces Target On USANA Health Ahead Of Q3 Results
Thursday, October 15, 2015 - 2:32pm | 336Read More...Analysts at Canaccord recently shared a preview of USANA Health Sciences, Inc. (NYSE: USNA)’s third-quarter results. Ahead of the earnings call, the firm reiterated a Hold rating on the stock, while trimming its price target from $136 to $131. Shares of USANA are down roughly 0.20 percent on...
-
Canaccord Analysts Recommend 'Aggressively Buying' AtriCure After Sell-Off
Tuesday, September 29, 2015 - 8:45am | 310Read More...AtriCure Inc (NASDAQ: ATRC) shares have lost 19 percent in the last three months, even after hitting their 52-week high of $28.15 in August. Canaccord’s Jason Mills maintained a Buy rating on the company, with a price target of $31. Recent weakness in the company’s shares and...
-
Box Inc Is Close To A Bottom, Canaccord Analysts Say
Friday, September 25, 2015 - 3:34pm | 364Read More...Canaccord upgraded shares of Box Inc (NYSE: BOX) from Buy to Hold on Thursday, as its decline seems close to an end. However, the firm maintained its price target of $18.00. Shares of Box are down almost 1 percent on Friday trading. Box’s stock has lost more than 44 percent since it started...
-
Petra: A Long-Term Way To Play Diamonds You Might Not Know
Friday, September 25, 2015 - 8:40am | 429Read More...In a report issued Thursday, Canaccord analyst Nick Hatch explains why he trimmed his price target for Petra Diamonds Limited (LON:PDL) from 170 pounds to 150 pounds. Despite the reduction in the price target, the firm maintains a Buy rating, and recommends buying it for the long term....
-
'Grass Is Greener' For Zynerba Pharma: Buy The Stock, Says Canaccord
Monday, September 14, 2015 - 3:44pm | 402Read More...In a report issued Monday, Canaccord analysts Corey Davis and Lidia Liu initiated coverage on shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) with a Buy rating. The experts set a $35.00 price target for the stock. The company is differentiated by its synthetic manufacturing and transdermal...
